We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.56%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$672M
AUM Growth
+$54.8M
Cap. Flow
+$50.6M
Cap. Flow %
7.53%
Top 10 Hldgs %
35.69%
Holding
5,893
New
1,202
Increased
1,600
Reduced
1,403
Closed
1,568

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.3M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$22.9M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$19.2M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$16.3M
5
XLI icon
State Street Industrial Select Sector SPDR ETF
XLI
+$14.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$227M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.4M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$9.03M
4
SH icon
ProShares Short S&P500
SH
+$5.21M
5
IHE icon
iShares US Pharmaceuticals ETF
IHE
+$4.93M

Sector Composition

Rank Sector Weight
1 Technology 5.35%
2 Consumer Discretionary 3.08%
3 Materials 2.71%
4 Industrials 2.51%
5 Financials 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
3026
Alnylam Pharmaceuticals
ALNY
$29.3B
$3K ﹤0.01%
40
-262
-87% -$17.4K
AROW icon
3027
Arrow Financial
AROW
$652M
$3K ﹤0.01%
142
-570
-80% -$11.9K
ASG
3028
Liberty All-Star Growth Fund
ASG
$341M
$3K ﹤0.01%
+674
New +$2.64K
ATEX icon
3029
Anterix
ATEX
$1.94B
$3K ﹤0.01%
100
+57
+133% +$1.51K
AVK
3030
Advent Convertible and Income Fund
AVK
$563M
$3K ﹤0.01%
205
-4,018
-95% -$49K
AVTX icon
3031
Avalo Therapeutics
AVTX
$983M
– –
0
– –
AXR icon
3032
AMREP Corp
AXR
$119M
$3K ﹤0.01%
693
+481
+227% +$1.94K
BBC icon
3033
Virtus Biotech Clinical Trials ETF
BBC
$49.9M
$3K ﹤0.01%
181
-215
-54% -$4.17K
BCLI
3034
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$3K ﹤0.01%
67
+51
+319% +$1.87K
BGS icon
3035
B&G Foods
BGS
$286M
$3K ﹤0.01%
+100
New +$3.53K
BKTI icon
3036
BK Technologies
BKTI
$291M
$3K ﹤0.01%
+126
New +$2.62K
BOOM icon
3037
DMC Global
BOOM
$157M
$3K ﹤0.01%
+437
New +$2.67K
BRX icon
3038
Brixmor Property Group
BRX
$9.32B
$3K ﹤0.01%
119
-1,862
-94% -$45.9K
BWFG icon
3039
Bankwell Financial Group
BWFG
$533M
$3K ﹤0.01%
+156
New +$3.06K
BWXT icon
3040
BWX Technologies
BWXT
$15.6B
$3K ﹤0.01%
+100
New +$3.09K
BBBY
3041
Bed Bath & Beyond
BBBY
$442M
$3K ﹤0.01%
321
-376
-54% -$3.67K
CCU icon
3042
Compañía de Cervecerías Unidas
CCU
$2.21B
$3K ﹤0.01%
150
-50
-25% -$1.02K
CDNA icon
3043
CareDx
CDNA
$2.42B
$3K ﹤0.01%
656
-3,568
-84% -$18.3K
CDZI icon
3044
Cadiz
CDZI
$291M
$3K ﹤0.01%
628
-3,990
-86% -$20.6K
CEF icon
3045
Sprott Physical Gold and Silver Trust
CEF
$8.06B
$3K ﹤0.01%
270
-4,230
-94% -$48.3K
CENTA icon
3046
Central Garden & Pet Co Class A
CENTA
$2.44B
$3K ﹤0.01%
250
-644
-72% -$7.21K
CHY
3047
Calamos Convertible and High Income Fund
CHY
$1.06B
$3K ﹤0.01%
276
-766
-74% -$7.4K
CIG icon
3048
CEMIG Preferred Shares
CIG
$6.01B
$3K ﹤0.01%
2,456
-31,413
-93% -$25.6K
CLIR icon
3049
ClearSign Technologies
CLIR
$25.5M
$3K ﹤0.01%
65
-279
-81% -$10.3K
CLRB icon
3050
Cellectar Biosciences
CLRB
$20.5M
– –
0
– –
120 121
122
123 124

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2016 Portfolio in Review

As of Q1 2016, Tower Research Capital (TRC) held 5,893 positions worth $672M, up 8.9% from $617M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $50.6M of net new capital in Q1 2016, opening 1,202 new positions and adding to 1,600 existing holdings. Its largest new stake was State Street Industrial Select Sector SPDR ETF: 287,194 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 1.4% a quarter earlier, followed by Consumer Discretionary and Materials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $227M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2016 buy was State Street Industrial Select Sector SPDR ETF: 287,194 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2016, an estimated $52.3M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $227M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P 500 ETF in Q1 2016, selling an estimated $9.03M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $672M portfolio in Q1 2016.
  • Tower Research Capital (TRC) opened 1,202 new positions and closed 1,568 in Q1 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 8.9% quarter-over-quarter to $672M.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2016, filed 16 May 2016.